- Appoints Dr. Raminderpal Singh to lead the practice
"20/15 Visioneers: Scientists,
Technologists, and Informaticians Helping R&D Organizations Get
the Most Out of Their Efforts by Holistically Improving Their
Culture, Data, Processes and Technology"
PHILADELPHIA and CAMBRIDGE, England, July 15,
2024 /PRNewswire/ -- Today, 20/15 Visioneers,
a leading science and technology management, strategy, and
marketing consultancy, announces the formation of a New AI &
Generative AI Practice to accelerate the impact of AI &
Generative AI on R&D processes and reduce operational
costs.
Dr. Singh has 30 years of business and AI
experience, including taking Watson Genomics to market for IBM
Research.
As pragmatic industry evangelists for computational techniques,
scientific informatics, and in silico-first strategies, 20/15
Visioneers recognizes that R&D companies need help to adjust
their culture, develop their strategy, and execute on game-changing
AI capabilities. 20/15 Visioneers has been helping R&D
organizations since 1999 to prepare for AI by revamping their data
culture, strategy, and platforms since 2019. In this new phase of
its growth, 20/15 Visioneers is harnessing its expertise and
vision into a focused, world-class practice.
"If you are not using AI or GenAI in your R&D processes
today you are most likely behind, which means you are operating
inefficiently and losing ground against your competitors and the
industry as a whole. The longer you delay, the harder it will be to
catch up", says John F.
Conway, Chief Visioneer Officer, 20/15
Visioneers.
To lead this new effort, Dr Raminderpal Singh has been
appointed as the Global Head of AI & GenAI Practice. In this
role, he will evangelize how to help R&D organizations. This
will include leading business development and delivering crucial
and critically needed AI consulting and professional services to
the R&D Industry. Dr Singh brings with him 30 years of global
business and AI experience across several industries, including
taking IBM Watson Genomics to market for IBM Research in
New York.
"AI and Generative AI technologies have rapidly evolved in the
last few years and continue to evolve. They have now reached a
point where they can generate useful R&D insights at a fraction
of the time versus manual approaches. However, domain knowledge and
experience are required to select and implement the right
technologies cost-efficiently and effectively. I am excited to lead
this new practice to address this market need", says Dr. Singh,
Global Head of AI & GenAI Practice, 20/15 Visioneers.
About 20/15 Visioneers
20/15 Visioneers is a rapidly
growing science and technology management consulting and marketing
think-tank comprised of industry-hardened scientists (data, lab,
computational) and informaticians. We are "Visioneering" the "Lab
of the Future," including next-generation science and new modality
challenges and problems.
Our domain expertise spans Life, Materials (including Consumer
Packaged Goods (CPG), and AgriTech Science. Our talented team are
proving know-how and expertise in scientific informatics strategy,
chemistry and bioprocess development, lab automation, Cloud Labs,
HTE (High Throughput Experimentation), NME (New Molecular Entity)
Discovery, Computational Sciences, Cheminformatics, Bioinformatics,
Microbiome, Multi-omics, New Modalities, and Information
Technology.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/2015-visioneers-launches-a-new-ai--genai-practice-to-accelerate-impact-on-rd-processes-302196572.html
SOURCE 20/15 Visioneers